HIV eradication: combinatorial approaches to activate latent viruses

Area of Science:

• Virology
• Immunology
• Pharmacology

Background:

• Combination Anti-Retroviral Therapy (c-ART) suppresses HIV replication but does not cure infection.
• Latent HIV reservoirs in infected cells persist despite c-ART, hindering eradication.
• Pharmaceutical research focuses on reactivating latent HIV for immune clearance.

Purpose of the Study:

• To review mechanisms for targeting HIV activation.
• To explore potential combinatorial therapeutic approaches for HIV eradication.
• To identify molecular targets for compounds that activate latent HIV.

Main Methods:

• Review of current literature on HIV latency and reactivation strategies.
• Analysis of molecular pathways regulating HIV promoter activity.
• Evaluation of potential drug targets for inducing HIV replication.

Main Results:

• Latent HIV reservoirs are a major barrier to eradication.
• Inducing HIV-1 replication from latently infected cells can enhance susceptibility to immune responses.
• Targeting HIV promoter activity and transcription complexes offers therapeutic avenues.

Conclusions:

• Combined therapies using multiple activators and depressors are likely most effective for HIV eradication.
• Targeting multiple pathways increases therapeutic efficacy and prevents viral escape.
• Combinatorial approaches are essential for overcoming HIV subtypes and integration site variability.